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Introduction
In 1970 Jaeger and Rubin (1) reported
detecting the presence of a asiize
di-2-ethylhexyl phthalate inEHF I issues
and organs of two deceased patients who
previously had received blood transfusions.
The blood had been stored in bags made of
poly(vinyl chloride) (PVC) plasticized with
EDHadEven thoug ther reports had implied
that certain formulations of PVC medical
tubings (2,3) and containers would, in fact,
release plasticizers as well as additives to
solutions, little concern had been expressed as
to the possible health consequences to
humans from leaching of these agents. Since
Jaeger and Rubin's publication, however,
considerable interest has developed con-
ceming the possible toxicogenic effects not
only of DEHP, but of all hthalate esters.
More recently, interest has lso cen O
the potential hazards from these plasticizers
in the environment. It is estimated that the
yarly production of phthalate esters in this
country is in the neighborhood of 900 million
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pounds (4). Since these esters have been
produced commercially in greater quantities
each year since the Second World War, it
should not be too surprising to find that they
are entering the environment. Currently no
restrictions have been placed on phthalates in
regard to industrial wastes, and thus large
quantities are being dumped into waterways
adjacent to industrial regions producing or
using the esters for various aDplications.
Phthalate esters ar ow ater-solubl ut
are readily seque r absorbed bv organic
residues and solid surfaces in environmental
water systems. Although there is no quanti-
tative information on the extent of such
phthalate ester deposition, either naturally or
from industrial or municipal wastes,
accumulation and slow, long-term release may
significantly affect the ecology of water
systems.
Since there is a growing concern that
phthalate esters may be a menace to health
and to our ecological system, there is a need
to review the evidence on the toxicity and
possible health threats that these esters
present directly or indirectly to man. This
paper reviews the story of the phthalate esters
in a manner which hopefully separates science
from fiction. Certain value judgments which
are included reflect the background and
experiences of the author. To those who have
become interested in the phthalate esters, this
June 1973 3review should be a good starting point from
which to pursue the subject in more detail.
Unfortunately, as will be evident, there are
still a large number of questions in regard to
potential health threats which cannot be
answered rationally on the basis of present
knowledge. It is hoped that this review will
stimulate research to fill the gaps of
knowledge. It is hoped that this review will
stimulate research to fill the gaps of knowl-
edge needed to make sound scientific judg-
ments in the near future as to benefits versus
risks of these very important chemical agents.
Chemistry a r
The term estes"s restricted to
the ortho aox
prepared by reaction o ut a
specific alcohol to form the desired ester.
r.~-COOH
I@I + 2ROH
COOH
COOR
COOR
+ 2H20
Ind_driaesY,these esters are prepared from
a ydri rather than from the acid.
Commercial phthalate esters generally are not
vure compounds, but reasonably pure com-
pounds can be prepared for specific appli-
cations. Most of the esters are colorless
liquids, have low volatility, and are poorly
soluble in water but soluble in organic
solvents and oils (Table 1).
Two other isomeric forms of benzene-
dicarboxylic acid esters are also available
having important industrial applications-the
-meta form (or isopthalate esters) and the
para form (or terephthalate esters).
'COOR
COOR
Isophthalates Terephthalates
Terephthalic acid and esters of this acid are
becoming increasingly important as starting
chemicalsforcertin types of polymers (i.e.,
Daumn)- and are used in animal feed To
enhance the physic- properties of the feed
and the bioavailability of added components
such as antibiotics. In 1970, some 420 X 106
lb of terephthalic acid was produced in this
country with a prediction (6) that up to 2.9 X
109 lb will be manufactured by 1979.
Isophthalates are also used industrially in the
production of certain types of polymers and
resins but not to the same extent as the
phthalates and terephthalates. This review for
the most part will deal with the phthalate
esters, but this should not be taken as an
indication that the isophthalates or tere-
phthalates may not also pose health and
ecological threats, but rather that sufficient
information is not available on these other
isomers to present a detailed review.
General Applications of Phthalate Esters
A very wide spectrum of uses has been
found for the various phthalate esters. During
the Second World War, dimethyl and dibutyl
phthalates were used in insect repellent
formulations. By far, however, the largest
market for these esters is as plasticizing agents
for poly(vinyl chloride), for example, the
cellulosics, and certain types of elastomers.
These plasticizers give the polymer the desired
flexibility and softness and may account for
up to 40% of the final weight of the material.
They are not chemically bound to the
pol meL, but dispersed in the matrix of the
polymer chains to decrease the interaction
forces of adjacent chains, lower the glass
transition temperature of the polymer, and
causes chain mobilitv and material flexibility.
Dioctyl phthalate (DOP) and its isomer,
-ethylhexvl phthalate IDEHP) are
probably the most widelv used plasticizers_
,tod although other phthalates are used,
sometimes in combinations, to give certain
additional properties desired in the final
material.
A large number of industrial and consumer
products of the poly(vinyl chloride) type will
generally contain one of the phthalate esters
as a plasticizer. These products include floor
tiles, various types of furnishings for house-
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Compound Molecular Specific Bp, Solubility in
weight gravity °C H20, g/lOO ml
Dimethyl 194.18 1.189 (25/25) 282 0.5
phthalate
Diethyl 222.23 1.123 (25/4) 296.1 Insoluble
phthalate
Diallyl 246.27 1.120 (20/20) 290 0.01
phthalate
Diisobutyl 278.3 1.040 327 Insoluble
phthalate
Dibutyl 278.34 1.0465 (21) 340 0.45 (250C)
phthalate
Dimethoxyethyl 282.0 1.171 (20) 190-210 0.85
phthalate
Dicyclohexyl 330.0 1.20 (25/25) 220-228 Insoluble
phthalate
Butyl octyl 334.0 - 340
phthalate
Dihexyl 334.0 0.990 - Insoluble
phthalate
Butylphthalyl 336.37 1.097 (25/25) 219 /5 mm/ 0.012%
butyl glycolate
Dibutoxyethyl 366.0 1.063 210 0.03
ethyl phthalate
Di-2-ethylhexyl 391.0 0.985 (20/20) 386.9/5 mm Insoluble
phthalate
Diisooctyl 391.0 0.981 239/5 mm Insoluble
phthalate
Di-n-octyl 391.0 0.978 220 /5 mm/ Insoluble
phthalate
Dinonyl 419.0 0.965 413 Insoluble
phthalate
aData of Patty (5a).
holds and transportation vehicles, food
packaging systems, industrial tubings and
conduits, medical tubings, catheters and
blood containers, certain types of dental
materials, coatings for drugs, and numerous
other products.
The phthalate esters also have many other
uses. For example, they are used as defoami
agents in the manufacture' of paper, in
cosmetic products as a vehicle (primarily
di-ethyl phthalatfor pertumes, in lubricating
oilsand in other industrial and consumer
applications in which the esters add specific
desired properties. There is also some
evidence suggesting that the esters are present
in certain plants and organisms as normal
metabolites.
Several of the phthalate esters have been
approved by the FDA for food-packaging
_applictns, and thus they have been ac-
cepted s
of use
Toxicology
Industrial Health Problems
Industrial production of very large quanti-
ties of phthalate esters has not generally
caused health problems where good industrLal
hygiene has been practiced. As in the manu-
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5facture of any chemical agent, many of the
starting agents in themselves may present
toxic and health liabilities to workers if care
and proper engineering methods are not
provided.
Since one of the starting materials for the
manufacture of phthalate esters is phthalic
anhydride, it is important to recognize the
toxic nature of this agent. Phthalic anhydride
is a solid (generally crystalline) and is slightly
soluble in water. It has a characteristic
choking odor and can be a moderate fire and
explosion hazard when exposed to heat and
flame.
The chief acute toxic effects result from
the very marked irritating properties of the
chemical on skin, eyes, and mucous mem-
branes of the nasal passage and upper
respiratory tract. On dry skin the irritant
properties are less, but in the presence of
moisture or water a highly inflamed tissue will
result. In susceptible workers, repeated con-
tact with the agent may cause allergic
dermatitis and perhaps pulmonary sensiti-
zation, leading to asthmatic attacks.
The oral LD50 in rats ranges from 800 to
1600 mg/kg; in the guinea pig the intra-
peritoneal LD50 dose is 100 mg/kg (5b).
If proper precautions are not taken in a
working environment, the worker may inhale
phthalic anhydride as a fine dust, resulting in
irritation of the mucous membranes of the
nose and copious nasal discharge with, at
times, bleeding. The TLV (Threshold Limit
Value, American Conference of Governmental
Industrial Hygienists, Cincinnati, Ohio) for
phthalic anhydride is 25 mg/m3. A number of
reports have appeared, primarily in European
publications, on the toxic and health hazards
of the anhydride, but few recent reports are
available in the American literature. Further
detailed information on this material may be
obtained from reports by Baader (7),
Menschick (8), Friebel (9), and Jacobs (10),
and several reference texts (11,12).
Depending on the specific phthalate ester
manufactured, various alcohols are used, each
of which presents specific toxic properties to
workers if general safety precautions are not
taken. The acute systemic toxicity of the
aliphatic alcohols increases with chain length,
reaching a maximum and then declining
parabolically due to decreased solubility and
changing intrinsic toxicity. Inhalation of
vapors of the alcohols will lead to narcosis,
which can cause accidents in the work
environment. Unsaturated alcohols are
generally more toxic than saturated, and
branched-chain alcohols are more volatile and
generally produce a greater central nervous
system depression than their straight-chain
isomers. Irritant effects on eyes and mem-
branes depend on the specific esterified
alcohol; diallyl phthalate, for example, is a
lacrimating agent. For the most part, the
alcohols have not presented serious industrial
hazards.
Acute Toxicity of Phthalate Esters
Up to the present, published literature on
the subject of phthalate esters has indicated
that these chemical agents are relatively non-
toxic and should not present any health
hazards to man. Animal experiments dating
back to the Second World War have shown
that the most frequently used phthalate esters
have an extremely low order of acute toxicity
(see Table 2). Esters of higher molecular
weight, such as dioctyl and di-2-ethylhexyl
phthalate, show a very low order of acute
toxicity. Lethal effects from absorption
through the skin of guinea pigs and rabbits are
also quite low, with reports of LD50 values
greater than 5, 10, or even 20 ml/kg.
Most of the phthalate esters have a low
volatility, and thus inhalation of these agents
generally does not present problems of an
acute nature. Experiments in which groups of
animals were exposed to various concen-
trations of the esters produced very few
effects except at relatively high chamber
concentrations. In many instances it was
necessary to heat the ester to 100 or 2000C to
reach sufficiently high concentrations in the
chamber to note toxic effects.
As a group, the phthalate esters produce
little irritant response (perhaps with the
exception of diallyl phthalate) when placed in
contact with animal and human skin. Few
reports have noted the irritant properties of
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Compound Animal Route L:60, Reference
g/kg
Dimethyl
phthalate
Diethyl
phthalate
Dimethoxyethyl
phthalate
Diallyl
phthalate
Dibutyl
phthalate
Diisobutyl
phthalate
Butyl carbobutoxy-
methyl phthalate
Dihexyl
phthalate
Dioctyl
phthalate
Di-2-ethylhexyl
phthalate
Butylbenzyl
phthalate
Dicapryl
phthalate
Dinonyl
phthalate
Dibutyl (diethylene
glycol bisphthalate)
Dialkyl 79
phthalate
aLD50 in ml/kg.
Mouse
Mouse
Mouse
Rat
Rat
Guinea pig
Rabbit
Mouse
Mouse
Rat
Rabbit
Mouse
Mouse
Rat
Rat
Guinea pig
Guinea pig
Mouse
Rat
Rabbit
Rabbit
Mouse
Rat
Rat
Rabbit
Mouse
Mouse
Rat
Guinea pig
Rat
Rat
Rat
Rabbit
Mouse
Rat
Guinea pig
Mouse
Rat
Rat
Rabbit
Guinea pig
Mouse
Mouse
Rat
Mouse
Mouse
Rat
Rat
Mouse
Rat
Oral
EP
IP
Oral
'p
Oral
Dermal
IP
lP
IIP
Oral
Oral
EP
Oral
EP
Oral
Dermal
FP
Oral
Oral
Dermal
EP F
Dermal
Oral
Dermal
Oral
EP
Oral
Dermal
Oral
IP
Dermal
IP
Oral
IP
Oral
Dermal
EP Oral
Oral
Oral
Oral
FP
7.2
3.6
1.58
2.4
3.38a
2.4
10.0a
2.8
2.8
5.06a
1.0
3.2-6.4
2.51
4.4
3.7
1.6-3.2
100.a
0.7
1.7
1.7
3.4a
4.0
3.05a
8.0
20.0a
12.8
4.50
3.75a
10.0a
14.6a
6.89
30.0
20.0a
13.0
50.0a
5.0a
14.2
26.0
50.0a
34.0
10.0
3.16
14.2
2.00
11.2
-11.2
11.2
>11.2
>20.00
>20.00
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(5c)
(5c)
(13)
(5c)
(14)
(5c)
(5c)
(5c)
(13)
(14)
(5c)
(5c)
(13)
(5c)
(13)
(5c)
(5c)
(5c)
(5c)
(5c)
(5c)
(13)
(14)
(5c)
(5c)
(5c)
(13)
(14)
(5c)
(5c)
(14)
(5c)
(5c)
(5c)
(14)
(5c)
(13)
(5c)
(14)
(5c)
(5c)
(13)
(13)
(5c)
(15)
(15)
(15)
(15)
(16)
(16)
7these compounds to the eye (again with the
exception of diallyl phthalate). However,
intradermal injections of some phthalate
esters in rabbits can lead to irritant responses
(Table 3) (13).
Table 3. Irritative response in rabbits to intradermal
injectionsofphthalate esters.-
Degree of extravasationb
Material injected 10 min 15 min 26 min
Dimethyl phthalate + + + + + + + +
Diethyl phthalate + + + +++ + + +
Dibutyl phthalate + + + +
Diisobutyl phthalate - - + +
Dimethoxyethyl phthalate + + + + + +
Butylbenzyl phthalate - + + +
Di-2-ethylhexyl + + + +++ + + +
phthalate
Dicapryl phthalate - + +
0.85% NaCI - - -
(negative control)
20% Ethyl alcohol + + + +++ + + +
(positive control)
aData of Calley, Autian, and Guess (13).
bInflammatory response indicated by degree of
dye extravasation: - no color (negative response); +
mild; + + moderate; + + + marked.
When poly(vinyl chloride) containing di-2-
ethylhexyl phthalate is implanted subdermal-
ly or intramuscularly in rats or rabbits, no
inflammatory response is seen (Materials
Science Toxicology Laboratories, University
of Tennessee Medical Units, Memphis, Ten-
nessee 38103, unpublished data). As yet, no
reports have stated that phthalate esters act as
sensitizing agents in animals or man. If there
is an inflammatory or sensitizing response to a
material, it most likely results from other
additives or contaminants.
Many of the commercially available
phthalate esters contain impurities, including
homologs and isomers. Nematollahi, Guess,
and Autian (17) synthesized and purified a
number of dialkyl and dicycloalkyl
phthalates, isophthalates, and terephthalates
and evaluated them for acute toxicity by a
tissue culture test and by intraperitoneal (IP)
injection into mice.
8
The mice, three in each group, received a
dose of 5 mole/kg in either cottonseed oil or
castor oil, depending on the solubility of the
specific compound, and were observed for 4
days or until death. The results (Table 4)
showed cytotoxic and toxic effects from the
lower molecular weight compounds but not
from esters with C6 to C9 alkyl groups. The
cyclohexyl phthalate, isophthalate, and tere-
phthalate esters were toxic, as was cyclo-
hexyl as the phthalate or isophthalate ester.
However, the terephthalate ester was not. The
n-Cl0H21 phthalate and terephthalate esters
were toxic, while the isophthalate isomer was
not. Some toxicity was manifested by the
n-C.2H26 phthalate esters, a slight toxic
effect by the terephthalate ester, but none by
the isophthalate.
Subacute and Chronic Toxicity of Phthalate
Esters
Repeated exposure to phthalate esters-
orally, IP, dermally, and by inhalation-
appears to produce few if any toxic effects in
animals except at very high doses or high
inhalation concentrations. Since the Second
World War the number of reports published
on groups of phthalate esters or on specific
esters have been relatively few, most being
published from 1945 to 1955. Since the total
quantity of the di-2-ethylhexyl phthalate
manufactured is much greater than that ofthe
other phthalate esters, more interest has been
shown in this plasticizer than in the others. In
the section to follow, several of the phthalate
esters are reviewed, but comments are brief
because of the paucity of information avail-
able. More attention is, however, directed to
DEHP, not only because of its great com-
mercial importance but also because of the
availability of toxicity data dealing with
subacute ch dies.
D lRepeated inhalation
of the vapor of dimethyl phthalate will cause
j~iafkn o th naal mlucous mmrn n jgiio-o, "r= and
the upper respiratory trct. Prolonged in-
hEaation may lead to central nervous system
depression and eventual paralys Dose levels
of 4 to 8% in the diet of female rats over a
Environmental Health PerspectivesTable 4. Toxicity evaluation ofthedialkylbenzene dicarboxylate on the mammalian cell cultures and mice.a
Phthalates Tsophthalate Terephthalates
Chick Chick Chick
embryo embryo embryo
R cells L-cells Mice cells L-cells Mice cells L-cells Mice
CH3 + + + + + + + + +
C2H5 + + + + + + + + +
n-C3H7 + + + + + + + + +
i-C3H7 + + + + + _ + + +
n-C4H9 + + + + + + + + +
i-C4H9 + + + + + + _ _ +
n-C5H11 - + - + + - + + +
i-C5H 1I + + + + + - + + _
Cyclo-C5H9 + + + + + + + + +
n-C6H13 - - _ _ _ _ _
Cyclo-C6H1 -
n-C7H15 _ _ _ _ + +
Cyclo-C7H13 + + - + + - - - -
n-C8H17
Cyclo-C8Hi5 - _ _ . + +
n-C9H.9 - - - + + _ _ ._
n-ClOH21 + + + - - _ + +
n-CI
+H23 + + i i
n-Cl2H25 + + +
aFor cell culture (chick embryo and L-cells) + indicates a cytoxic response, - indicates noncytotoxic, and ±
a questionable response. For mice + indicates 2 or 3 deaths, ± indicates 1 death; and - indicates no deaths. Data
of Nematollahi, Guess, and Autian (17).
2-yr period produced a slight reduction in
growth, but 2% did not (5d). At the 8% dose
level there was noticeable kidney damage.
Single applications of dimethyl phthalate to
the skin of rabbits indicated a dermal LD50
value of greater than 10 ml/kg, which, how-
ever, was only somewhat greater than 4 ml/kg
when repeated applications were made over a
90-day period. '
Lptll Phthalate:he small amount of
information available from chronic toxicity
studies and human experience of a quarter of
a century of use suggest an extremely low
toxic ote f diethyl phthalate. Like
"-iiiethyl phthalate, prolonged inhalation of
vapors of this ester may produce irritant
responses in the nasal passage and on the
mucous membrane of the upper respiratory
tract. Generally, however, only if the ester is
heated will sufficient concentration of the
vapor become available to produce anirritant,
response (5e'.
Dibutyl Phthalate: In chronic toxicity
stes, Smith (1 ound the lethal oral dose
of dibutyl phthalate to be approximately 8.0
g/kg in rats. Rats fed diets containing 0.01,
0.05, and 0.25% dibutyl phthalate showed no
toxic reactions after 1 yr. Of those fed 1.25%,
half died during the first week of the experi-
ment, but those which survived grew normal-
ly, asompare ty Glyo Bpha)
Dbutyl(Diethylene Glycol Bisphthalate)
Dibutyl(diethylene glycol biptaae)
(DDGB) was synthesized as a promising new
plasticizer for moisture-proof coatings on
cellulose film. Hall, Austin, and Fairweather
(15) found the oral LD50 of a commercial
sample of DDGB that contained approx-
imately 80% DDGB, 15% dibutyl phthalate,
and 59% di(diethylene glycol) phthalate to be
greater than 11.2 g/kg and the IP LD50 to be
approximately 11.2 g/kg. The acute toxicity
of the product was greater when it was admin-
istered as a 50% solution in arachis oil.
June 1973 9In a 12-week subacute toxicity study, rats
fed a diet containing 0, 0.25, and 2.5% ofthe
product showed a marked retardation of
growth as compared to control animals (15).
Enlargement of liver and heart was noted at
the 1.0 and 2.5% level in male rats and
enlarged brain in both male and female
animals. Oxaluria and hematuria were noted
in both male and female rats at the 2.5% level,
the oxaluria being assumed to be a direct
result of the in vivo liberation of diethylene
glycol (a known producer of oxalate stones in
the bladder). Since dose levels below 0.25%
were not tested, no information is available as
to the "no adverse effect" level.
/Dialkyl 79 Phthalate:) Dialkyl 79
phthalate is a plasticizer which contains a
mixture of phthalate esters of alcohols having
chain lengths of 7 to 9 carbons. Elizarova (19)
reported that the oral LD50 for mice is
greater than 44 ml/kg and for rats is in excess
of 70-80 ml/kg. In other acute toxicity
studies with doses of 20.0 g/kg dialkyl 79
phthalate, Gaunt et al. (16) found no deaths
when mice or rats were given doses of 20.0
g/kg orally or by intraperitoneal injection. A
90-day feeding study in rats demonstrated no
adverse effects at the 0.125% level, but 0.5
and 1.0% resulted in increased liver weights
even though histopathologic changes were not
evident. The authors concluded after
imposing a 100-fold safety factor, that a
60-kg adult could ingest 36 mg/day without
any apparent harm.
IDi-2-ethylhexvl Phthalate Di-2-ethylhexyl
phthalate (DEHP) has an extremely low
order of acute toxicity. The LD50 values in
several species of animals (Table 2) indicate
that extremely large doses, 14.2 to greater
than 50 g/kg, of the compound are neces-
sary to produce lethal effects. In fact, this
agent would be classified as "practically non-
toxic" by the toxicity rating system of
Gleason et al. (20). No irritant response
from dermal application or sensitizing poten-
tial has been noted in animals or humans.
The ester is very poorly absorbed through
skin, very large concentrations (approxi-
mately 25 ml/kg) being necessary to bring
about death in rabbits. In early experiments
by Shaffer and associates (21), in which
groups of rats were exposed to DEHP mists
generated by bubbling air through DEHP
heated to 1700C in a chamber maintained at
room temperature, there were no fatalities in
2 hr. but all the animals died in 4 hr.
Much of the information on the subacute
and chronic toxicity of DEHP has come
from reports by Shaffer et al. (21),
Carpenter et al. (22), and Harris et al. (23),
spanning a period of approximately 12 years
(1945 to 1956). Since 1956 no published data
on chronic toxicity have appeared in the
American literature. Because of the recent
resurrection of interest in DEHP, newer sub-
acute and chronic studies have been initiated,
but these data are not available as publica-
tions yet although a few may be available as
preliminary reports.
Shaffer and associates, as early as 1945
(21), reported a subacute study in rats oh the
toxicity of DEHP, which was administered in
the diet at concentrations of 3.0, 1.5, 0.75,
and 0.375% for 90 days. At the three highest
levels there was a slight decrease in growth as
compared to control rats, and at the two
highest doses tubular atrophy and degenera-
tion in the testes were observed. However, no
abnormal blood picture was noted at any of
the doses. The authors concluded that no
injury resulted from oral administration of
0?2 g/kg per day or less, while a slight retarda-
tion in growth occurred at 0.4 g/kg per day.
Metabolism experiments conducted by
Shaffer are disc4qsed below.
In 1953, Carpenter, Weil, and Smyth (22)
published a chronic oral toxicity study on
DEHP, using rats, guinea pigs, and dogs. The
rat experiment was designed as follows.
Groups composed of 32 male and 32 female
Sherman rats constituted the parental (P1)
generation rats, which were maintained for a
maximum of 2 yr on diets containing 0.4,
0.13, and 0.04% DEHP. In addition,
approximately 80 first filial generation (F1)
rats were maintained for 1 yr on a diet
containing 0.4% DEHP. Appropriate controls
for each group received the basal diet without
the chemical additive. The criteria of effect
chosen for statistical evaluation by direct
Environmental Health Perspectivescomparison with the untreated controls were
mortality, life expectancy, body weight, food
consumption, liver and kidney weights, micro-
pathological changes, neoplasm incidence,
hematology, and fertility.
The plasticizer was added to the diet when
animals attained an age of 60 days. Male and
female rats on the 0.4% DEHP were mated,
and pregnant females were isolated until they
gave birth and the pups were weaned or died.
The pups were removed from the mother
after they had reached an age of 15 days, at
which time they received a diet similar to the
mother's. A portion ofthe animals in P1 were
sacrificed at the end of 1 yr of feeding ofthe
plasticizer, and the rest at the end of the
second yr. All animals in F1 were sacrificed at
the age of 1 year.
Over the 2-yr period there were a number
of deaths in both the P1 experimental animals
and P1 controls, but there was no indication
that the treated animals had higher mortalities
than the control animals. The majority of
deaths were ascribed to lung infections. In the
F1 groups, the treated (at 0.4% DEHP) and
nontreated animals had a similar mortality
rate during the 1-yr study. It was interesting
that the life expectancy of the P1 groups
receiving diets containing 0.4 and 0.13%
DEHP exceeded that of the control group
even though these were found not to differ
significantly from the control animals.
At the 0.4%level. both the P1 and F1 male
animals had significantly lower body weights
than the control animals, but the lower levels
of DEHP appeared not to affect the weight
gain. Food consumptions for the P1 and F1
animals were not significantly different from
those of the controls at the end of the first
year. Also at the 0.4% DEHP level, the mean
liver and kidney weights were significantly
greater for male P1 rats after 1 yr, but
controls did not differ significantly at any of
the DEHP levels.
No tissue or organ pathology was evident
which could be attributed to DEHP at any of
the levels tested in the P1 and F2 groups. No
hematologic changes were observed in the
treated animals which were significantly
different from controls. Fertility did not
appear to be altered in the treated animals
except in the case of F1 rats at the 0.4%
DEHP level and this effect was not considered
significant by the authors.
In a separate study, guinea pigs were
administered 0.13% and 0.04% DEHP in the
diet for 1 yr (22). No real differences in
deaths, growth, life expectancy, food con-
sumption, liver and kidney weights, and
pathology were observed which could be
ascribed to the esters. The only unusual effect
noted was that the kidneys of females on the
0.13 and 0.04% dose levels were larger than
those of the controls, but the authors did not
judge this as being deleterious.
The same investigators also included a 1-yr
dog study in which the animals were
administered, in capsules, 0.03 ml/kg per day,
5 days a week, for the first 19 doses and then
0.06 ml/kg per day until 240 doses were
given (22). The results of this study demon-
strated that DEHP had no significant effect
on body welght, nor was there any significant
difference between liver and kidney weights
of treated animals and those of controls. One
dog in the experiment initially received 0.06
ml/kg for a total of 77 doses with no ill
effects and then received 0.09 ml/kg until an
additional 169 doses had been administered.
In this dog fatty vacuolation and limited
congestion were observed in the liver as well
as moderate congestion of the kidney. No
apparent gross or microscopic pathology of
tissues or organs of dogs was noted with the
0.06 ml/kg dose as compared with controls.
The authors ascertained that a no-effect dose
over a 2-yr period fell between 0.06 and 0.2
g/kg per day for rats and was approximately
0.06 g/kg per day for the guinea pig and dog.
No evidence developed implicating DEHP as a
carcinogenic agent.
In 1956, Harris, Hodge, Maynard, and
Blanchet (23) published results of a chronic
toxicity study on DEHP in rats and dogs
undertaken in order to verify the results of
previous studies. The ester was administered
to rats, both male and female, in the feed at
0.5%, 0.1%, and 0.0% levels. Groups of
animals were sacrificed at 3, 6, 12, and 24
months, and body weights, food con-
sumptions, and organ weights (liver, testes,
kidneys, lungs, brains, stomach, heart, and
June 1973 11spleen) were noted. Gross and histo-
pathological studies were carried out on
selected tissues and organs. Even though
mortality of the treated animals was high over
the 2-yr period, the number of deaths did not
differ significantly from those in the control
group. After 1 yr at the highest dose level
(0.5%), the average weights of the animals
were approximately 50 'g less than those of
the controls, and in the second year the
average weights of the animals in the 0.5%,
0.1%, and 0.0% (control) groups were
approximately the same. However, the total
number of animals in all of the groups were
quite small due to deaths and sacrifices. No
significant differences were noted in food
consumption up to 6 months for the treated
animals as compared to the controls, but at
the end of the first year the food con-
sumption decreased drastically in the 0.5%
group with little difference in the 0.1% group
as compared to controls. At 6 months, en-
larged livers and kidneys were observed in the
animals on the 0.5% DEHP diet.
Two dogs were also used in this study; one
was administered 5 g/kg per day for 14 weeks.
A no-effect dose of 0.1 g/kg per day was
ascertained. S.me adverse effects were noted
in the dog receiving 5.0 g/kg. Results of the
studies in rats and dogs were in general similar
to those reported by Carpenter et al. (22) in
1953.
Brown, Muir, and Thorpe (24) admin-
istered daily oral doses of 5 mg/kg of phtha-
lates, having alcohol chain lengths varying
from 7 to 11, to groups ofrats for 7 consecu-
tive days. There were no overt signs of
toxicity other than general depression and
persistent wetness of the hair. Histopatho-
logical studies of the organs showed periportal
cytoplasmic vacuolation due to fat deposition
in the liver.
In an unpublished report, Lawrence con-
ducted a subacute toxicity study on DEHP by
administering three dose levels of the ester
subcutaneously to groups ofrats, once a week
for 12 weeks i.e., 5.0 g/kg, 100 mg/kg, and 25
mg/kg (W. H. Lawrence, Materials Science
Toxicology Laboratories, University of
Tennessee Medical Units, Memphis, Ten-
nessee, unpublished data). Weight gain, food
consumption, and general health of the
animals were observed, and at the end of the
study, organ-to-body weight ratios were deter-
mined and hematological studies, BSP liver
tests, and gross and histopathologic
examination of tissues and organs were
performed. No significant differences were
noted for any of the criteria measured, at any
of the doses, compared to the control
animals. Selected organs were extracted, and
thin-layer chromatography was used to detect
the presence of DEHP. At the 5.0 g/kg and
100 mg/kg levels, DEHP was detected in the
liver and kidney. The ester was also detected
in the serum of the rats receiving the highest
dose level. Since a total of 12 doses was
administered at weekly intervals, the results
cannot be compared to oral feeding studies
lasting a year in which daily doses were given.
As already stated, the acute toxicity of
DEHP is quite low as reflected by the LD50
(Table 2). In order to determine whether
repeated administration of DEHP and DOP
(dioctyl phthalate) would produce a cumu-
lative toxic effect in mice, Lawrence adminis-
tered several dose levels of these compounds
IP to groups of mice 5 days per week for 11
weeks. The LD50 values, calculated on a
weekly basis, are shown in Table 5.
At the end of the first week the LD50 of
DOP was 6.40 ml/kg, which gradually
decreased and plateaued at 10 weeks at 1.37
ml/kg. These results indicate that in some
manner DOP has a cumulative toxic effect in
these animals, since the compound was 4.67
times as toxic at 10 weeks as at the end ofthe
first week. The LD60 of DEHP for the first
week was found to be 25.41 ml/kg, which
declined to 3.06 ml/kg by the end of 11
weeks; i.e., the material was 8.31 times as
toxic at the end of 11 weeks as at the end of
1 week.
Since it is possible that animals and
workers may be repeatedly exposed to DEHP
by inhalation, Lawrence conducted an
experiment in which air was bubbled through
DEHP at a temperature of 500C; the vapors
were then cooled and passed into an inhala-
tion chamber containing mice. The mice were
exposed to these vapors for 1 hr three times a
week for 12 weeks and observed for deaths
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Apparent LD50, ml/kg (95% confi'dence level)
Dioctyl phthalate Di-2-ethylhexyl phthalate
Week (DOP) (DEHP)
(5.0120-8.1772)
(2.8945-4.5497)
(2.2843-3.5440)
(1.7125-2.4710)
(1.5669-2.2963)
(1.4127-1.9960)
25.4111
12.7544
9.2212
7.8408
7.5292
6.4019
(1.3777-1.8881)
(1.2826-1.7246)
(1.2227-1.6680)
(1.1714-1.6055)
(1.1714-1.6055)
4.4446
3.3548
3.2134
3.0856
3.0586
(20.3338-31.7557)
(10.8275-15.0334)
( 7.2300-11.7681)
( 6.3055- 9.7500)
( 6.0053- 9.4400)
( 3.4953- 5.6516)
( 3.4953-
( 2.6356-
( 2.5507-
( 2.4304-
( 2.4304-
5.6516)
4.2486)
4.0482)
3.9177)
3.9177)
aData of H. L. Lawrence, Materials Science Toxicology Laboratories, University of Tennessee Medical Units,
Memphis, unpublished data.
and other untoward responses. During this
time, no deaths or unusual behavior were
observed. At the end of the study the animals
were sacrificed. The lungs, removed for gross
and histopathologic examination, showed
signs of diffuse chronic inflammation similar
to a burn reaction. Since the chamber tem-
perature did not exceed 27-28°C, it may be
concluded that the pathology of the lungs was
due directly to DEHP and not to a thermal
effect.
Absorption, Distribution, Excretion, and
Metabolism
Absorption: Phthalate esters can be
absorbed frm the intestinal tract, the intra-
peritoneal cavity, and the lungs. Even though
dermal absorption is low with the higher
molecular weight phthalate esters, recent
evidence indicates that those of lower
molecular weight, such as diethyl phthalate,
may pass through the skin more rapidly than
originally suspected. In particular, this was
observed in rabbit experiments in which
14C-diethyl phthalate was placed on the skin,
and approximately 9% of the activity was
recovered in the urine after 24 hr (E. 0.
Dillingham and M. Pesh-Imam, Materials
Science Toxicology Laboratories, University
of Tennessee Medical Units, Memphis, Ten-
nessee, unpublished data).
Distribution: Jaeger and Rubin (1) found
that organs of two patients who had received
large volumes of blood IV from DEHP-
plasticized PVC blood bags contained signif-
icant quantities of DEHP. Presumably this
substance was released to the blood during
storage in PVC blood bags or by blood passing
through PVC tubings. DEHP was found in
spleen, liver, lung, and abdominal fat, with
concentrations ranging from 0.025 mg/g in
spleen to 0.270 mg/g in abdominal fat. In
another study by these same investigators,
27% of an IV-administered dose of DEHP was
recovered in the lungs of rats after 24 hr (R.
J. Rubin, Johns Hopkins University School of
Hygiene and Public Health, Baltimore, Mary-
land, personal communication).
Dillingham and Pesh-Imam, in studies with
14C-DEHP in which mice were injected with a
single IV dose (unpublished data), found that
after 7 days the highest specific activity was
in lungs, with lesser amounts in the brain, fat,
heart, and blood and no apparent preferential
deposition in fatty tissue. In a similar
experiment, except that 14C-DEHP was
administered IP, after 14 days the lungs still
retained the-highest specific activity as com-
pared to the other organs and tissue. This
information thus parallels the results of Jaeger
and Rubin. In a third experiment, a large dose
of unlabeled DEHP was administered IP,
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2
3
4
5
6
6.4017
3.6288
2.8453
2.0579
1.8968
1.6796
7
8
9
10
11
1.6128
1.4872
1.4271
1.3714
1.3714
13followed 3 days later by an IV dose of
14C-DEHP. Seven days later the mice were
sacrificed and the same organs and tissues
examined for the presence of labeled DEHP.
The lungs again showed the highest concen-
tration (activity) of DEHP. A similar 14-day
experiment involving IP administration only
and a 7-day experiment involving IV
administration only showed essentially the
same results, although the absolute amounts
of phthalate ester (radioactivity) remaining in
the organs at 14 days was less.
In a further set of experiments by Dilling-
ham and Pesh-Imam using 14C-DEP (diethyl
phthalate), the ester was applied to the skin
of rabbits and tissue distribution was deter-
mined qualitatively by autoradiography of
tissue sections. After 3 days of dermal
exposure, radioactivity was detected in lung,
heart, liver, kidney, gonads, and spleen. The
radioactivity was not random but showed
distinct intracellular localization. Surprisingly
enough, skin and subdermal fatty tissue at the
site of application showed no radioactivity.
The presence of the compound (or its
metabolite) in the brain indicated the blood-
had been penetrated.
cret n: Shaffer et al.(21), in one of
the fewSt stes on the excretion of phthalate
esters, as early as 1945 reported the presence
of phthalates (as phthalic acid) in the urine of
ma dogs and rabbits after single oral doses
of DEHP, indicating that the ester is absorbed
from the intestine. The human experiment
was performed on two males: one receiving
10 g of DEHP and the second 5 g. Excretion
of phthalate equivalent in the urine after 24
hr came to 4.5% of the total dose adminis-
tered for the subject having received the
highest dose and 2.0% for the subject with the
lower dose. Results of the dog experiments
followed the same general trend of excretion
as noted for the human subjects. These
investigators noted that rabbits excrete high
levels of DEHP, equivalent to 26 to 65.4% of
the original dose, in 3 days. Although quanti-
tative determinations were not made, con-
siderable amounts of DEHP equivalent were
apparently excreted in the urine by the rats.
Urinary excretion of 14C-DEHP by mice
receiving pure phthalate ester IP and saturated
saline solution of the ester IV was studied by
Dillingham and Pesh-Imam (unpublished
data). Excretion following IV administration
was only slightly higher and closely paralleled
that observed following IP administration,
68% and 63% respectively of the total dose
having been excreted by 7 days (Fig. 1). The
IV dose was lower than the IP by a factor of
104. A first-order decline 'in the daily
excretion rate was observed following IV
administration (Fig. 2). After reaching a peak,
excretion followed a first-order decline with
IP administration. The combined IP-IV
experiment used the same dose levels as the
independent IP and IV experiments and was
carried out in the same manner except that
the IP-administered DEHP was unlabeled and
the IV administration of 14C-DEHP was on
the third day following the IP administration.
The daily excretion rate (Fig. 2) and the
cumulative (Fig. 3) following IV adminis-
tration of the labeled compound were calcu-
lated on the assumption that the IV-
administered ester reached rapid and com-
i
0
w I-
w ,
I-0
n
z
0
LL
a
H
w
a-
00r
90F
80
701
601
501.
401
30[
20
10
0 I.P Administrotion
0/)CE I.V. Administrotion
I I I I
2 4 6 8
DAYS
10 12 14 16
Figure 1. Cumulative urinary excretion of 14C-DEHP
by mice: ( 0 ) IP administration; ( 0 ) IV adminis-
tration.
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plete equilibrium with the residual unlabeled
DEHP pool (approximately 77% of the IV-
administered dose) at 3 days. The close
agreement of the cumulative IV and IP curves
is consistent with the assumption of rapid
equilibrium and with the conclusion that the
DEHP pool at 3 days had not been metob-
olized to any large degree.
Approximately 83% of the total IP-
administered dose was excreted by 14 days,
and no significant radioactivity was found in
the urine of mice after 35 days. A very
interesting aspect of this study, is that despite
rapid excretion at 1400 days, there remained
in the mice an amount of DEHP beyond that
necessary to saturate the aqueous com-
partment of the body. An unresolved
question is why the cumulative excretion rate
(Fig. 3) shifts from zero order to first order at
approximately 4 days at a time when there is
approximately 20 times the amount ofDEHP
present required to saturate the aqueous
compartment. A small amount of the ester
(radioactivity)- was detected in the feces but
was not enough to account for any significant
depletion of the pool. Also, the vapor pres-
sure of the ester is too low to account for any
significant losses by expiration, although this
was not investigated.
A significant diuretic effect was observed
following IV administration of the DEHP-
saturated saline solution and a distinct sup-
pression of urinary excretion following the IP
injection of the pure ester. It was noted,
however, that IV administration of the
DEHP-saturated solution in the combined
LP-IV experiment did not lead to diuresis, the
urinary excretion volumes remaining
approximately the same as for the IP
experiment.
Rabbits with dermally applied labeled
diethyl phthalate were found to excrete (in
the urine) approximately 9% of the labeled
activity after 24 hr, 14% after 48 hr, and
approximately 16-20% within 72 hr. (Dilling-
ham and Pesh-Imam, unpublished data).
Excretion by other routes, such as in the feces
or through exhaled air, was not followed.
Some of the loss of the compound may have
occurred at the site of application due to
sorption into the cotton patches used to cover
the application sites.
A very important question which still needs
to be answered is the possible accumulation
of phthalate esters in the body. If these esters
are sequestered in some manner in specific
organs and tissues of the body, will the body
burden be exceeded, bringing about subtle
toxic effects which may not be apparent until
many months or years later? As of now, no
information is available to indicate that body
burdens are being exceeded or even what may
be considered as a tolerable body burden.
Metabolism: It would be expected that
esters of phthalic acid, under appropriate
conditions, would hydrolyze, releasing
phthalic acid and an alcohol. As with other
biological aspects of phthalic esters, infor-
mation on metabolism is minimal and at times
O V INJECTION, 14C-DEHP
* P INJECTION, UNLABELED DEHP AT ZERO TIME
DAYS
Figure 3. Urinary excretion of 14C-DEHP admin-
istered IV to mice on day 3 after IP injection of
nonlabeled DEHP: ( 0 ) IV injection, 14C-DEHP:
( 0 ) IP injection, unlabeled DEHP at zero time.
June 1973 15quite vague. One of the few published studies
on Metabolism, in this case on DEHP,
appeared in the experiments by Shaffer et
al. (21). These investigators noted that urine
of man, dogs, rabbits, and rats contained
phthalic acid after administration of DEHP
orally. By their methods they were not able
to identify the ester as such in the urine.
Thus, the question may be raised whether, if
DEHP is metabolized in the body, the acute
toxicity of the administered ester would be
due to (1) the alcohol, (2) phthalic acid, or
(3) perhaps a combination of alcohol,
phthalic acid, and ester. Shaffer et al. (21) in
further experiments on the acute toxicity of
phthalic acid, 2-ethylhexanol, and DEHP,
found LD50 values in rats of 7.9 g/kg (slope
16.11 ± 7.80), 7.1 g/kg (slope 4.09 ± 2.64),
and 30.6 g/kg (slope 1.92 ± 0.98), respec-
tively. The slopes of the LD50 curves of the
alcohol and ester were similar, but the slope
of the acid curve differed markedly, indi-
cating that the alcohol and ester may have
similar modes of action. It appears that, at
least in rats, phthalic acid is not metabolized
further, but this may not be the case for other
species. Shaffer and associates concluded that
the toxicity of the original ester is most likely
due to the alkyl portion of the molecule
rather than to the ester or acid.
Even though Hall and associates (15) did
not specifically study the metabolism of
dibutyl(diethylene glycol bisphthalate), they
made a tentative conclusion that the oxaluria
produced by high doses of DDGB was a result
of the release of diethylene glycol, indicating
that the plasticizer was biotransformed in the
body.
In the more recent paper by Jaeger and
Rubin(l), the conclusion was reached that
butyl glycolylbutyl phthalate (BGBP) can be
metabolized by the liver, whereas DEHP can-
not. However, these experiments were run in
isolated rat liver preparations. If deesterifi-
cation takes place in the kidney in the process
of excretion, the results are not incompatible.
As more metabolic studies are performed in
animals and humans with the various esters,
more light may be shed on what actually does
take place in the body.
Teratogenic, Mutagenic, and Carcinogenic
Effects
(Teratogenic Effects, errett et al. (25)
demonstrated that a number of compounds,
including phthalic acid, phthalimide, and
phthalamide, related to thalidomide had
teratogenic potential in the developing chick
embryo. In another study by Guess et al. (26)
on the subtle toxicity of a number of agents
and ingredients used in the preparation of
polymeric materials, chicks whose embryos
had been exposed to phthalate esters showed
deformities. These results suggested to Bower,
Haberman, and Minton (27) that a more
definitive study should be undertaken on the
teratogenic and embryotoxic effects of the
more useful phthalate esters, using chick
embryos as the test organism. In such a study
conducted on eight esters, dibutoxyethyl
phthalate produced congenital malformations
described as crania bifida and anophthalmia.
Marked exophthalmia was also observed in
some of the chicks. Central nervous system
damage was noted in newbom chicks
receiving dibutoxyethyl phthalate, di-2-
methoxyethyl phthalate, and octyl isodecyl
phthalate.
Singh, Lawrence, and Autian (14) studied
the embryotoxicity and teratogenic effects of
several phthalate esters in rats, which were
injected IP at three different dose levels
(1/10, 1/5, and 1/3 of the acute LD50). Two
of the compounds, i.e., dioctyl phthalate and
di-2-ethylhexyl sphthalate, because of their
very low acute toxicity, were administered in
doses of 5 and 10 ml/kg. All treatments took
place on the 5th, 10th, and 15th day of
gestation. After 20 days, the rats were
sacrificed with an overdose of ether, and the-
uterine horns and ovaries were surgically
exposed to permit counting and recording of
the number of corpora lutea, resorption sites,
and viable and dead fetuses. Additionally, the
fetuses, both viable and nonviable, were ex-
cised, weighed, and examined for gross mal-
formations. One third to one half of the
fetuses, using those which showed no gross
malformation whenever possible, were pre-
pared as transparent specimens to permit
visualizations of skeletal deformities. All the
Environmental Health Perspectives 16esters, to some degree, produced gross or Mutagenic Effects: No published informna-
skeletal abnormalities which were dose-related tion is available on the mu nic effects of
(Table 6). Dead fetuses were found in groups phthalate esters. In preliminary unpublished
treated with dimethyl, dimethoxyethyl, and' studies, Singh and associates of these labora-
diisobutyl phthalates. The most embryotoxic tories, using mice and dominant-lethal assay,
agent was dimethoxyethylphthalate. All the noted that both DEHP and DMEP appeae
esters decreased -the size of the fetuses, as to act as mtuenc ise
evidenced by lower weights than controls. re1Futher confirming information, how-
Dioctyl and di-2-ethylhexyl phthalate seemed eVer, is still needed to establish that these
to have the least adverse effect on embryo- esters are indeed mutagenic or may present
fetus development. Since lower doses were this hazard to man.
not used, a no-adverse-effect dose could not Carcinogenic Effects: No animal data have
be ascertained. yet demonstrated that any of the phthalate
Table 6. Gross and sketetal abnormalities produced by phthalate esters in rats.a
Treatment In- Gross ab- Skeletal ab-
jected, Resorptions normalitiesb normalitiesb
ml/kg No. % No. % No. %
None None 0 0 0
Distilled water 10.00 4 6.8 0 0
Normal saline 10.00 7 11.5 1 1.9 4 14.3
Cottonseed oil 10.00 4 6.8 1 1.8 3 10.7
5.00 3 6.4 0 0
Dimethyl 1.125 17 32.1 4 11.1 9 75.0
phthalate 0.675 0 4 7.5 6 35.3
0.338 21 33.3 4 9.5 4 25.0
Dimethoxyethyl 1.245 55 96.5 2 100.0 2 100.0
phthalate 0.747 52 89.7 5 83.3 4 100.0
0.374 16 27.6 1 2.4 13 92.9
Diethyl 1.686 2 3.6 0 13 81.3
phthalate 1.012 0 0 8 47.1
0.506 28 44.4 0 5 26.3
Dibutyl 1.017 23 36.5 0 8 33.3
phthalate 0.610 2 3.6 0 7 24.1
0.305 4 7.3 0 6 20.7
Diisobutyl 1.250 16 25.8 0 8 33.3
phthalate 0.750 3 5.5 2 3.9 5 17.2
0.375 5 9.6 0 4 14.8
Butyl carbo- 2.296 13 24.1 1 2.4 5 21.7
butoxymethyl 1.378 8 14.5 1 2.1 4 16.0
phthalate 0.689 4 7.8 0 4 13.8
Dioctyl 10.00 5 8.3 15 27.3 0
phthalate 5.00 2 3.8 8 15.7 0
Di-2-ethylhexyl 10.00 15 26.8 9 22.0 0
phthalate 5.00 5 8.2 0 0
aData of Singh, Lawrence, and Autian (14).
bPercentage resorption based on total number of implantations, gross abnormalities based on total number of
fetuses, and skeletal abnormalities based on total number of stained fetuses.
June 1973 17esters act as carcinogenic agents. Likewise,
their role as possible co-carcinogens has not
been established.
Cellular Toxicity
As is apparent from this review, the acute
toxicity of the phthalate esters in animals and
humans is quite low under the experimental
conditions used in evaluating the biological
effects. There may, however, be more subtle
toxic effects which up to now have not been
revealed. For this reason, information at a
cellular level may be helpful to those
interested in the toxicity of phthalate esters
in the broadest sense. Information in this
specific area, as with many of the other areas
of phthalate ester toxicity, is still quite
limited.
Effect on Mouse Fibroblasts: Dillingham,
Chambers, and Autian determined the effects
of several phthalates on growth inhibition of
mouse fibroblasts (L-cells) in tissue culture
(unpublished data). By plotting the per-
centage growth vs. concentration, they
obtained dose-response curves from which the
ID50 values (or dose required to inhibit
growth by 50%) could be estimated. From the
slopes, of these curves, the "intrinsic tox-
icities" Ti of the esters in cell culture were
evaluated (shown in Table 7 with LD50 values
for comparison). The in vivo toxicity, as
evident fxom LD50 values, increased in
general with molecular weight except for
dibutyl phthalate, which was the most toxic.
Tissue culture toxicity, as evident from IDso
values, increased with increasing molecular
weight with the exception of dimethoxyethyl
phthalate, which was the least toxic. The
intrinsic toxicity in tissue culture followed
the same trend but had a much wider range of
variation, approximately 7 X 105 fold.
On the assumption that the in vivo toxicity
should be proportional to the product of the
intrinsic cellular toxicity and the water
solubility (or maximum effective water con-
centration in vivo), the authors found the
relation for the phthalate esters investigated
to be as follows.
TiM,5/LD50 = Constant
The relative constancy of the ratios (Table
8) suggests that for these compounds the
intrinsic toxicity in vitro (in cell culture) and
in vivo (in the rat) are basically the same. It
also suggests that the water solubility of the
compounds is directly related to the effective
concentrations attained in vivo under the
conditions used in the LD50 assay. In other
words, the toxicity potential of the ester at a
cellular level, whether in cell culture or in
the intact animal, is related to the con-
centration of the agent in the aqueous
environment in contact with the cells
and the intrinsic toxicity of the com-
pound. Although this simple empirical
relation between in vivo and in vitro toxicity
raises a number of basic questions relative to
the nature and mechanism of expression of
toxicity in the two systems, the authors have
demonstrated a similar relation between in
vivo and in vitro toxicity for a series of
halogen- and methyl-substituted alcohols
(28).
Warren and Glick (29) reported that the
specific activity of the membrane and particu-
late fractions of mouse fibroblasts in labeled
medium increased at a rate independent of
cell division. Further, they showed a rapid
Table 7. LDr0, ID50, and intrinsic toxicity ofagroup ofphthalates.
Water
Mol. solubility LD50, ID50, T, X 103,
Phthalate wt. (M.),mole/l mole/kg mole/I. %/M
Dimethyl 194 0.0263 0.0235 0.007 14.3
Diethyl 222 0.0048 0.0202 0.003 47.0
Dibutyl 278 0.008 0.0138 0.0001 184,000
Dimethoxyethyl 282 0.0400 0.0159 0.0084 5.6
Di-2-ethylhexyl 390 0.0004 0.0151 0.00005 3,750,000
Environmental Health PerspectivesTable 8. TlJM/LD60 Values ofagroup ofphthalate esters.a
Phthalate TiMs/LD50
Dimethyl 16,004
Diethyl 11,169
Dibutyl 12,000
Dimethoxyethyl 14,088
Di-2-ethylhexyl 11,680
aTi is the intrinsic toxicity in cell culture and M.
is the molar solubility in water; LD50 is taken from
rat experiments. The units are included in Table 7.
turnover of protein in nondividing cells.. This
led them to surmise that a protein synthesis
rate in excess of that required by cell division
may account for increased instability of the
cell and increased susceptibility to toxicants.
Dillingham, Wu, and Autian (published data)
noted, in studies on dimethyl and dimethoxy-
ethyl phthalate in cell culture, that these
agents were highly toxic during the time that
the cells were undergoing significant protein
turnover. Even though these results cannot
now be directly extrapolated to toxic events
in animals, they suggest that any tissue which
exhibits periodic increases in protein turnover
related to changes in cell division rate and
metabolic activity (protein synthesis) has an
increased susceptibility to the toxic effects of
phthalate esters. This may account for the
teratogenic and embryotoxic effects ofseveral
of the phthalate esters reported in rats, since
differentiating embryonic tissues have peri-
odic major changes in cell division rates and
metabolic activity.
Effect on Formed Elements of
Blood: Some concern has been raised that
perhaps phthalate esters which can enter
patients through the use of poly(vinyl
chloride) tubings and blood bags may be
acting on formed elements of blood such as
platelets, leukocytes, and erythrocytes. Cir-
cumstantial evidence suggests that at least
some of the esters may change membrane
properties, leading to adhesions of platelets
and leukocytes (30). If these events can
occur, microemboli may form and become
lodged in the capillary tissues of the lungs.
Occurrence of microemboli in patients who
are highly debilitated may account for the
syndrome of "shocked lungs," leading to
death of the patient. Much more research is
needed, however, in this specific area before
factual information is available to substantiate
what has been suggested.
Phthalates and Medical Devices
A large number of cubings, blood bags,
infusion containers, surgical gloves, catheters,
surgical drapes, and other medical items are of
poly(vinyl chloride), containing rather large
concentrations of phthalate esters, primarily
DEHP. Cellulosic membranes used in dialysis
units may also contain a phthalate ester.
When these items are in contact with blood or
infusion solutions or directly with tissue,
there is a possibility that the esters as well as
other additives may migrate from the material
to the solution or tissue. As early as 1960,
Meyler, Willebrands, and Durrer (31), in
isolated rat heart experiments, noted that
certain types of PVC tubings used in the
perfusion apparatus would release additives
from the plastic to the solution, which would
affect the heart. Since in addition to the
phthalate plasticizer the tubings contained
stabilizers such as organotin compounds, the
cardiotoxic effect may have been due to the
plasticizer, to the organotin compound, or to
both. The authors tentatively concluded that
the organotin was most likely responsible for
the cardiotoxic effects.
Cruickshank et al.(32) investigated the
toxicity of rubbers and plastics used in
transfusion sets. They noted that specific
rubbers and certain PVC tubings were highly
cytotoxic to cell cultures. Again, the toxic
effects from the PVC-may have been derived
from the additives in the plastic rather than
from the phthalate ester. In these experiments
there was no attempt to isolate and identify
the offending agents.
Braun and Kummel (33) in 1963 reported
their results on a group of plastic containers,
including PVC, used for storing blood and
transfusion solutions. Most of their tests, both
physical and chemical, were done on aqueous
extracts of the plastic. They noted that the
PVC material released phthalate ester as well
as other additives to the extracting water.
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blood cells in in vitro tests. Since the
phthalate esters, of themselves, are not con-
sidered hemolytic agents, the hemolysis noted
by Braun and Kummell most likely resulted
from the presence of one of the additives.
In the mid-sixties, Lawrence et al. (34),
testing a large number of PVC tubings which
were parts of commercially available adminis-
tration devices, noted that a large number of
these tubings produced various degrees of
irritation when samples were implanted in the
muscle of rabbits for short times. It was
assumed that an organotin stabilizer was the
offending agent and that the plasticizer,
assumed to be DEHP, acted as a vehicle
carrying the organotin into the immediate
tissue.
Trimble et al. (35) reported that butyl
phthalylbutyl glycolate (BPBG) was being
extracted from PVC, tubings, which were
being used for extraction of blood and brown
fat of groundhogs. The extracts, in turn,
showed biological activity which was attrib-
uted originally to substances from the animal
but later to the contamination of the extract
with BPBG.
Guess, Jacob, and Autian (2), in 1967,
published results on chemical contamination
of a number of American PVC blood bags
containing anticoagulant solution (ACD). All
the anticoagulant solutions stored in these
bags for up to 1 year were found to contain
small concentrations of DEHP, 2-
ethylhexanol, phthalic anhydride, phthalic
acid, and some unidentified chemicals. The
authors suggested that steps should be taken
to prevent the 'contamination. Or, if the
contamination was limited, a complete
toxicological profile (gross and subtle) should
be developed for these substances to demon-
strate their safety.
Other investigators have now noted that
PVC tubings and devices can release phthalate
plasticizers to solutions, with the quantity of
plasticizer extracted increasing as the solution
becomes more lipoidal (blood, serum, etc.).
For iexample, Jaeger and Rubin (36), in 1970,
reported that blood and its anticoagulant
solution (ACD) may contain 6 mg of
DEHP/100 ml after being stored in PVC
blood bags at 4°C for 21 days. In a more
recent study, Jaegerand Rubin (1) noted that
several phthalate esters could be extracted by
blood from PVC tubings and blood bags. This
report also showed for the first time that
phthalate esters were present in tissues and
organs of two deceased patients previously
having received large volumes of blood,
presumably stQred in PVC blood bags.
During the past year in this country, PVC
infusion containers have been introduced into
medical practice. These containers may con-
tain 250, 500, or 1000 ml of different types
of aqueous solutions which will be adminis-
tered to patients requiring large volumes of
these specific fluids. The solutions are
aqueous, and questions have been raised as to
the possibility of plasticizers being released to
these solutions. One specific manufacturer
(Viaflex Plastic Container, Travenol Labora-
tories, Inc., Morton Grove, Ill.) includes on a
label insert the following. "Solutions in con-
tact with the plastic container can leach out
certain of its chemical components in very
small amounts within the expiration period,
e.g., dioctylphthalate (DOP), up to 5 parts per
million; however, the safety of the plastic has
been confirmed in tests in animals according
to U.S.P. biological standards for plastic
containers as well as by tissue culture toxicity
studies." Even though the plasticizer above
has been identified as DOP, it is most likely
DEHP.
Rubin has studied a number of these newer
PVC infusion containers containing such
solutions as: 0.9% saline, 5% dextrose, and 5%
protein hydrolyzates (37). The solutions were
stored in the containers for longer than 1 year
under different ambient temperatures. The
author was not able to detect the presence of
DEHP in any of the three solutions greater
than the blank value of the assay system used.
These results thus differ from those of Guess
et al. (2), who found DEHP in ACD solutions
stored in blood bags. This suggests that the
newer PVC containers are an improved ver-
sion of those used by Guess and associates. It
should, however, still be kept in mind that
blood and solutions that are lipoidal in nature
will extract microquantities of phthalate
esters (as well as perhaps other additives) and
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Marcel and Noel (38), for example, found
high concentrations of DEHP in lipid extracts
of human blood that had been stored in a
PVC transfusion pack.
Even though the implication -is given that
phthalate esters may play a role in causing
adhesiveness of platelets and leukocytes
leading to microemboli, it should be noted
that other types of containers may also cause
the formation of microemboli. Swank (39)
and Connell and Swank (40) have studied this
problem and have suggested that "aged" bank
blood be filtered in a specific manner prior to
transfusion.
In 1971 a report by Neegaard et al. (41)
implied that diethyl phthalate was the cause
of several cases of hepatitis in a hemodialysis
unit in a hospital. The plasticizer was present
in a PVC tubing used in the dialysis apparatus.
Removal of these specific PVC tubings for
other PVC tubings (not containing diethyl
phthalate) eliminated the health hazard. Since
organotin compounds may have been present
in the diethyl phthalate-PVC tubing, it is
possible that these agents may have played a
role in causing hepatitis (42). Present experi-
mental evidence does not indicate that diethyl
phthalate alone will cause hepatic damage in
animals.
With the advent of the plastic blood bag
(principally PVC with plasticizers and addi-
tives) in the 1950's, a number of studies were
conducted to determine the effect these new
containers had on whole blood or blood
components as compared to these products
stored in glass. Since the exact formula of
these PVC containers was generally never
revealed, it is now nearly impossible to
attempt to compare results from one study to
another. Wall et al. (43) observed that ery-
throcytes stored as whole blood in glass
containers survive better than when stored in
two types of plastic containers (from two
different manufacturers of blood containers
and assumed to be PVC). Strumia et al. (44)
reported in 1955 that certain plastic con-
tainers appeared to damage red cells, reducing
the post-transfusion survival rate, while other
plastic containers produced a definite
beneficial effect on red cells. A study pub-
lished in 1964 by Ozge, Baldini, and Gold-
stein (45) indicated that platelet-rich plasma
stored in plastic lost its clot-retracting and
serotonin-uptake properties more rapidly than
when the product was stored in silicone-
coated or uncoated glass containers. In the
ensuing years, improvements have been made
in the PVC blood bags, and thus previous
observation on the potential deleterious
effects of PVC on stored blood and blood
products may no longer be valid.
Environmental Problems
The approximately 900 X 106 lb of
phthalate esters produced each year in this
country dwarfs the production of both DDT
and the polychlorinated biphenyls (PCP),
which have now been established as threats to
the environment. Since the phthalate esters
are used in a large number of applications,
from plasticizers to defoaming agents, the
potential for their release to the environment
is apparent.
Interest in the environmental aspects of
phthalate esters is relatively recent. Mayer,
Stalling, and Johnson (46) presented a report
in 1971 implicating the phthalate esters as
environmental pollutants. For example, in a
limited survey in which they were measuring
organochlorine insecticides and PCP residues,
they noted that phthalate esters were also
present. Fish contained dibutyl phthalate
ranging from 0 to 500 ,g/kg, while DEHP
concentrations were as high as 3200 mg/kg. It
was assumed that these fish had been exposed
to industrial wastes containing the esters.
These authors rationalized the source to be
the diet, which probably had previously been
contaminated in some way with the ester.
The same report stated that dibutyl
phthalate has a relatively low level of acute
toxicity to fish. But, since chronic toxicity
studies had not been conducted, no infor-
mation could be given as to the long-term
effects of the ester on fish. The same authors
did, however, report that the crustacean
Daphnia magna, when exposed to 0.1 Mg/l. of
labeled dibutyl phthalate in a continuous-flow
apparatus, accumulated phthalate residue
amounting to 600 jig/kg within 10 days (or a
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placed in uncontaminated water, 50% of the
labeled phthalate was excreted in 3 days.
Perhaps more significant was the discovery
that a concentration of only 3 ,g/l. of DEHP
in the water was sufficient to significantly
decrease growth and reproduction of the
crustacean. In view of these observations and
of the demonstrated teratogenic and
mutagenic properties of phthalate esters in
mice and rats and their toxicity in tissue
culture, a question is raised as to the effect of
these compounds on the reproductive pro-
cesses of higher aquatic organisms.
Miyoshi and Harada (47) published a paper
in 1970 which suggests very strongly that
certain microorganisms have the ability to
biosynthesize phthalate esters. Specifically,
they found that a soil bacterium (bacterial
strain BD34) could utilize 2-butyne-1-4-diol
to form two compounds, one being dibutyl
phthalate. It is not apparent from the article,
however, what precautions were taken to
prevent contamination during the processing
and analysis of the compounds.
Phthalate esters have been reported as be-
ing present in kewda (48), tobacco leaf (49)
and lily of the valley (50), but the chemical
structures of the esters have not been eluci-
dated. Hayashi and associates (51) were able
to identify a number of phthalate esters
present in a perennial vegetable cultivated or
growing wild in many regions of Japan, viz.,
dimethyl, diisobutyl, isobutyl n-butyl,
dibutyl, diisoamyl, diamyl, dihexyl, and di-2-
ethylhexyl. The authors did not state if they
believed that the esters were biosynthesized,
nor was there any indication as to the
possibility that contamination had or had not
occurred.
It appears plausible to assume that a variety
*of biological species may have the ability to
biosynthesize phthalate esters even though
information on this subject is quite limited.
Sugiyama et al. (52) in 1966 reported the
isolation and identification of diphenyl
phthalate from a fungus (Alternaria
kikuchiana Tanaka) which is pathogenic to
pears grown in Japan. The authors concluded
that the phthalate ester as well as a number of
other agents found in the fungus were normal
metabolites.
Since phthalate esters are being reported in
different locations in the world and, in
particular, in water bodies far removed from
industrial centers, the question of how the
phthalates reach these sites keeps arising.
Information is now becoming available to
indicate that trash no longer is confined to
populated regions but that solid wastes are
being seen thousands of miles from land. This
past year there was a report that various types
of plastic items have been found in ocean
waters, indicating that these items are
becoming man-made pollutants far removed
from the source of manufacture and use (53).
Since a number of these plastic items may
contain phthalate esters as plasticizers, it is
possible that these esters are being released to
the ocean and, in turn, are being ingested by
various types of marine organisms, including
fish.
A more probable mechanism of transport
of phthalate esters from sources of manu-
facture and use to remote sections of the
country and world is through complexation
with natural organic substances. For example,
the esters may interact with fulvic acid which
is present in humic substances in soils and
waters. Since the fulvic acid-phthalate ester
complex is soluble in water, the relatively
insoluble esters can readily be carried off in
water to othersections of streams, lakes, and
oceans. Ogner and Schnitzer (54) have, in
fact, found four phthalate esters (di-2-
ethylhexyl, dibutyl, dicyclohexyl, and benzyl
butyl phthalate) in humic substances as com-
plexes with fulvic acid. These authors were
extremely careful to preclude the possibility
that these esters were contaminates and took
very stringent steps in their processing to
prevent contamination. Even though they
leaned on the theory that the phthalate esters
were most likely due to pollution, they did
not completely rule out the fact that one or
more of these same esters may have been
biosynthetically produced in the humic
material. It is clear, however, from their study
that, if phthalate esters are discharged in one
or more ways to soil and water, they can
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ported away from the original site of
pollution.
The work of Jaeger and Rubin (1) showed
that phthalate esters could indeed be entering
man by exposure to large volumes of blood
stored in PVC blood containers. Since this
publication, however, phthalate esters have
been noted in the blood and urine of persons
known not to have received large-volume
parenteral therapy from PVC containers
(Rubin and Jaeger, personal communication).
These phthalates may have entered the human
body by several means, including ingestion in
the diet, absorption through the skin, and
inhalation. In certain other instances, the
phthalate ester may have been biologically
synthesized by the body. Nazir et al. (55), for
example, isolated di-2-ethylhexyl phthalate
from the mitochondrial fractions of bovine,
rat, rabbit, and dog heart muscle, taking
special pains to prevent contamination of
their samples with objects containing
phthalate esters. Other tissues which were
examined were devoid of the ester. Not yet
proved, however, is the possibility that the
DEHP may have originally entered the
animals through the diet or, perhaps, through
inhalation.
Even though most of the phthalate esters
have low volatility, they will volatilize from
plastic materials, as, for example, in the case
of automobiles containing vinyl furnishings.
In hot climates the phthalate is released from
the material and apparently coats micro-
particles, which then become distributed
through the car environment, often coating
the surface of the window (56).* This has
apparently caused some problems by
decreasing vision, and one major automobile
company has now eliminated the use of
DEHP in their interior furnishings. Impli-
cations of potential health hazards from
inhaling these particles of DEHP have still not
been defined, but one must certainly be
concerned that long-term exposure could
* The news item did not give the exact name of
the plasticizer in PVC, but it may be assumed to be
one of the phthalates.
bring about subtle toxic effects not evident
clinically at this time. Since humans may also
be absorbing phthalate esters by other means
such as from the diet or through the use of
various types of cosmetic items in which
phthalates may be used as perfume bases, the
body burden may be adequate to produce a
health hazard under conditions of prolonged
exposure.
Health Threats
Do the phthalate esters present a health
threat to the population, either as a direct
consequence of exposure or indirectly
through ecological disturbance? Definitive
answers to this question cannot be given at
this time. From the review, however, it can be
stated that in general the phthalate esters have
a very low degree of acute toxicity to animals
and man. Long-term feeding studies in several
species of animals, which indicate that a
no-effect dose may range from approximately
0.1 to 0.2 g/kg per day, have for the most
part used phthlate ester (DEHP). Assuming
that this range is also applicable to humans,
and imposing a 100-fold safety factor, a
70-kg man in a normal state of health could
ingest from 70 to 140 mg of DEHP on a
daily basis for long periods of time without
its presenting an appreciable health hazard.
Unfortunately, what is still not known is the
level of exposures man has to DEHP and, in
general, to all the phthalate esters, keeping
in mind that it is now known that the esters
can enter the body through a number of
routes including the mouth, the skin, the
lungs, and even, on occasions, through
parenteral administration.
Even though it is highly unlikely that
pregnant females will be exposed to suffi-
ciently high levels of phthalate esters to
produce embryotoxic effects and birth
defects, caution should prevail, and expectant
mothers should be afforded maximum
protection against these esters. Circumstantial
evidence also suggests that the phthalate
esters may act as mutagenic agents, but this
cannot be established as fact until more
research is conducted in this specific area of
June 1973 23toxicology. Much less is known on the pos-
sible subtle toxic effects that low doses of
phthalate esters may have on man, but
research at the cellular level does indicate that
the higher molecular weight esters have an
extremely high intrinsic toxicity.
Ill patients, in particular debilitated
patients requiring large volumes of blood or
other infusion solutions, should not be ex-
posed to any of the phthalate esters if at all
practical. Here "benefit to risk" must be the
deciding factor, but as yet the phthalate risk
is poorly defined.
A very real situation appears to be
developing in regard to phthalate esters as
environmental pollutants. Even though
minimal evidence is at hand demonstrating
environmental damage by phthalates, the
information does point to the possible toxic
effect of the phthalate esters on marine life.
To prevent potential ecological organisms and
their surroundings, steps should be taken to
restrict the quantity of phthalate esters
entering our streams, rivers, lakes, and oceans.
Even though at the present time phthalate
esters do not pose an imminent health threat
to our environment and to man directly, their
continued and expanding use and disposition
without some form of controls could pose
long-range tragedies for mankind. The high
benefit to risk ratio in the past may not
prevail in the near and distant future. Only
through continued and expanded toxi-
cological research and research dealing with
the relation of these esters to man's environ-
ment will a more accurate and realistic
"benefit to risk" be established for these
esters in the future. One step which most
likely should be taken now is to start en-
couraging industry to restrict the dumping of
phthalate esters into adjacent water bodies.
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